Changes of circulating anti-A/B-antibody titers during the preparation period and after AB0-incompatible living donor kidney transplantation

Changes of circulating anti-A/B-antibody titers during the preparation period and after AB0-incompatible living donor kidney transplantation

Several protocols have been developed to overcome the blood group barrier in renal transplantation. In the evolution of these protocols, one of the latest steps was the combination of anti-CD20 treatment with antigen-specific immunoadsorption (IA) and intravenous immunoglobulin (IvIg). This protocol...

Full description

Bibliographic Details
Main Authors: A. I. Sushkov, Ya. G. Moisyuk
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Transplantologiâ
Subjects:
kidney transplantation
blood group incompatibility
rituximab
immunoadsorption
Online Access:https://www.jtransplantologiya.ru/jour/article/view/335

Similar Items

Similar Items